You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 3, Sept 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Siderocalciphylactic Sensitization to Distilled Water

HANS SELYE, M.D., Ph.D., D.Sc.; JEAN-MARIE DIEUDONNE, M.D.; BEATRIZ TUCHWEBER, M.Sc.

Arch Intern Med. 1962;110(3):290-294.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Calciphylaxis is a condition of induced systemic hypersensitivity in which, during a "critical period" after sensitization by a systemic calcifying factor (e.g., vitamin-D compounds, parathyroid hormone), treatment with certain challengers (e.g., metallic salts, albumen) causes an acute local calcification followed by inflammation and sclerosis. The term was coined in analogy with such designations as "anaphylaxis" or "tachyphylaxis" that likewise refer to induced systemic alterations in the body's responsiveness to certain challenging agents. Apparently calciphylaxis is a fundamentally adaptive (phylactic) response that leads to defensive inflammation and sclerosis through the selective deposition of calcium in the challenged area. However, like many other basically defensive reactions (e.g., serologic immunity), it can also become the cause of morbid lesions.1

Topical calciphylaxis induced by the subcutaneous injection of challengers results in a cutaneous calcinosis reminiscent of calcareous scleroderma. Indeed, by the intravenous administration of challengers that have a particular affinity for one or . . . [Full Text PDF of this Article]


Author Affiliations

MONTREAL, CANADA

Institute of Experimental Medicine and Surgery, University of Montreal (Dr. Selye, Professor and Director).


Footnotes

Submitted for publication Feb. 27, 1962, accepted for publication April 10, 1962.

This work was supported by the National Institutes of Health, U.S. Public Health Service (Grants No. A-1641, B-2037, and H-6182) and by a Consolidated Grant from the Medical Research Council of Canada.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.